Drugs Made In America Acquisition Corp. Units (DMAAU) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Drugs Made In America Acq...

    NASDAQ: DMAAU · Real-Time Price · USD
    10.36
    -0.23 (-2.17%)
    At close: Sep 26, 2025, 11:44 AM
    10.36
    0.00%
    Pre-market: Sep 26, 2025, 11:44 AM EDT

    Drugs Made In America Acquisition Units Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024
    Period Ending Dec 31, 2024
    Revenue
    		 n/a
    Cost of Revenue
    		 n/a
    Gross Profit
    		 n/a
    Operating Income
    		 -479
    Interest Income
    		 n/a
    Pretax Income
    		 -479
    Net Income
    		 -479
    Selling & General & Admin
    		 479.73
    Research & Development
    		 n/a
    Other Expenses
    		 n/a
    Operating Expenses
    		 479.73
    Interest Expense
    		 n/a
    Selling & Marketing Expenses
    		 n/a
    Cost & Expenses
    		 479.73
    Income Tax Expense
    		 n/a
    Shares Outstanding (Basic)
    		 8.57K
    Shares Outstanding (Diluted)
    		 8.57K
    EPS (Basic)
    		 -0.06
    EPS (Diluted)
    		 -0.06
    EBITDA
    		 n/a
    EBIT
    		 -479
    Depreciation & Amortization
    		 479.73

    Add to Watchlist